Authors


Erica V. Stein

Latest:

NIST Spectroscopic Measurement Standards

The National Institute of Standards and Technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pathlength standard for UV absorbance measurements for use with the new generation of microvolume spectrophotometers and short-pathlength cuvettes.


John Schiel

Latest:

NIST Spectroscopic Measurement Standards

The National Institute of Standards and Technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pathlength standard for UV absorbance measurements for use with the new generation of microvolume spectrophotometers and short-pathlength cuvettes.


Brian Lang

Latest:

NIST Spectroscopic Measurement Standards

The National Institute of Standards and Technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pathlength standard for UV absorbance measurements for use with the new generation of microvolume spectrophotometers and short-pathlength cuvettes.


Hua-Jun He

Latest:

NIST Spectroscopic Measurement Standards

The National Institute of Standards and Technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pathlength standard for UV absorbance measurements for use with the new generation of microvolume spectrophotometers and short-pathlength cuvettes.


Jean-Marc Cappia

Latest:

An Integrated Approach to Shipping Liquid in Single-Use Systems

Increased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.


Ewelina Flamm

Latest:

Supplier-Change Management for Drug-Product Manufacturers

An effective supplier-initiated change management process is discussed.



Jill E. Sackman, PhD

Latest:

Market Access Outlook for Australia

The Australian pharmaceutical market offers opportunities for manufacturers despite challenges.


Susanne Keitel

Latest:

Finished Product Monographs in the European Pharmacopoeia

The European Pharmacopoeia Commission re-evaluates its policy on the development of monographs for finished drug products.


Jerold M. Martin

Latest:

Design and Qualification of Single-Use Systems

The author provides a review of the concepts of design and qualification that apply to single-use systems.


Simon Chalk

Latest:

Best Practices in Facility Design

Integrating advances in facility design can meet differing and emerging bioprocessing needs.


Hellen Berger

Latest:

Finding Opportunities in Brazil

Changes in the country’s political landscape may affect the pharmaceutical industry market in the future.


Sophia Kenrick

Latest:

Metacomplex Formation and Binding Affinity of Multivalent Binding Partners

A study to investigate metacomplex formation in the hetero-association of a multivalent antigen, streptavidin (SA), and a bivalent antibody (Ab) using a composition-gradient multiangle light-scattering (CG-MALS) system consisting of a composition-gradient device, a MALS detector, and a UV/Vis absorption detector.


Daniel Some

Latest:

Metacomplex Formation and Binding Affinity of Multivalent Binding Partners

A study to investigate metacomplex formation in the hetero-association of a multivalent antigen, streptavidin (SA), and a bivalent antibody (Ab) using a composition-gradient multiangle light-scattering (CG-MALS) system consisting of a composition-gradient device, a MALS detector, and a UV/Vis absorption detector.


Desmond G. Hunt

Latest:

First USP Workshop of its Kind Focuses on Particulates in Biologics

Along with particulate control and determination, speakers at the June conference in Rockville, Maryland, examined the role of protein aggregation and immunogenicity


Stephen Ball

Latest:

Measuring Protein Mobility with Electrophoretic Light Scattering

The author describes a method to avoid protein aggregation when using light scattering systems.


Patricia Van Arnum

Latest:

Pfizer, Teva Settle Patent Litigation on Viagra

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.


Maura C. Kibbey, PhD

Latest:

First USP Workshop of its Kind Focuses on Particulates in Biologics

Along with particulate control and determination, speakers at the June conference in Rockville, Maryland, examined the role of protein aggregation and immunogenicity


Patrick Jackson

Latest:

Stability in Biopharmaceutical Storage

Patrick Jackson of Vindon Scientific offers key considerations for choosing an outsourced sample storage facility.


Angie Drakulich

Latest:

A Look Ahead at BioPharma Manufacturing and Regulation

FDA talks about the changing scope of regulatory science.



Amy Ritter, PhD

Latest:

Translating Stem Cells From Laboratory to Clinic

Ontario-area scientists discuss approaches to development of stem-cell therapies.


Stephanie Sutton

Latest:

Drug Discovery Initiative Launched in Europe

An international consortium of pharmaceutical companies, academia, research organisations and other related entities have launched a new platform to help enhance drug discovery in Europe.


Carolyn M. Orelli

Latest:

A 25-Year Retrospective on GMP Training

This month, we rewind to an article titled "Good Manufacturing Practices Training."


Tina S. Morris, PhD

Latest:

USP Product-Class Standards for Biologics

US Pharmacopeia develops and improves its class approach for ensuring quality biopharmaceuticals.


Michelle Hoffman

Latest:

Passion, Innovation, and Loss

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.


G. Steven Burrill

Latest:

Moving the Needle on Healthcare

Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.


Lloyd Wolfinbarger, Jr., PhD

Latest:

Free Startup Research

Patent databases are often overlooked as a source of basic science, research, and development


K. John Morrow, Jr., PhD

Latest:

Angiopoietins: Novel Targets for Anti-angiogenesis Therapy

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.


Uwe Gottschalk, PhD

Latest:

The Future of Downstream Processing-2013

As constant scale up grows out of favor in the biopharmaceutical industry, new-and old-approaches are required. The author reviews the state of downstream processing and considers potential solutions, including the streamlining of full processes and borrowed technologies

© 2025 MJH Life Sciences

All rights reserved.